CRP and depressive symptom measurement: This study aims to understand if promoting adherence to the MedDiet, as an adjuvant strategy in the treatment of MDD, is effective to decrease symptoms of depression in patients diagnosed with MDD with high levels of inflammation biomarkers, namely elevation of CRP and/or IL-6 at baseline.